Pfizer

Small is better for vaccine shares - THE EDGE SINGAPORE

Covid-19

Small is better for vaccine shares

Investors who bet on success in the race to develop coronavirus vaccines are finding that smaller is better.

BOS sees clear skies over markets following US elections  - THE EDGE SINGAPORE

Broker's Calls

BOS sees clear skies over markets following US elections

While Donald Trump’s refusal to concede this year’s US Presidential Election has generated significant political controversy, market watchers remain unperturbed about the prospect of political unre

Analysts mixed on SATS despite potential Covid-19 vaccine, air travel bubble - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on SATS despite potential Covid-19 vaccine, air travel bubble

Analysts are divided on the prospects of SATS despite positive news for the aviation industry.

STI continues upward trajectory on better results, vaccine optimism - THE EDGE SINGAPORE

STI watch

STI continues upward trajectory on better results, vaccine optimism

The benchmark Straits Times Index (STI) rose 34.69 points or 1.28% as at 12.58pm to 2,746.08 on Nov 16 on hopes of a working Covid-19 vaccine, as well as on better 3Q results.

SIA gets a lift from potential Covid vaccine and travel bubble but recovery still nascent - THE EDGE SINGAPORE

Company in the news

SIA gets a lift from potential Covid vaccine and travel bubble but recovery still nascent

Shares of Singapore Airlines (SIA) this past week received a booster shot given the positive news concerning the aviation industry.

Company in the news

SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO

Airline caterer SATS, which also handles airfreight and other gateway services, has the capabilities to transport the experimental Covid-19 vaccine developed by Pfizer, according to CEO Alex Hungat

DBS Research bets Covid-19 recovery hopes on Covid-19 vaccine in 2021 - THE EDGE SINGAPORE

Broker's Calls

DBS Research bets Covid-19 recovery hopes on Covid-19 vaccine in 2021

As Covid-19 continues to devastate the global economy, DBS Research analyst Yeo Kee Yan and his team have placed their hopes for economic recovery on the successful development of a viable vaccine.

Global review

China could well be the winner of the Covid-19 vaccine race

China may have already won the race. Five of the 10 vaccines that are undergoing Phase Three trials are by Chinese pharmaceutical companies.

Covid-19

Is a viable Covid-19 vaccine imminent?

(July 22): Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can trai

Be informed of the stories that matter

×